(Erstwhile UTI Pharma & Healthcare Fund) Table of Contents The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis UTI Healthcare Fund - G
Scheme Objective
CAGR
return of 15.4% since its launch. Ranked 40 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . NAV as on 2 Dec 24 ₹290.505 ↑ 2.88 (1.00 %) Net Assets (AUM) as on 31 Oct 2024 ₹1,187 Cr. Launch Date 28 Jun 1999 Category Equity - Sectoral Rating ☆ Type Open Ended Fund Risk High AMC UTI Asset Management Company Ltd Alpha Ratio -2.15 Expense Ratio 2.38 % Sharpe Ratio 2.805 Information Ratio -0.28 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 2 Dec 24 Duration Returns 1 Month 1.9% 3 Month 3.8% 6 Month 30.2% 1 Year 45.9% 3 Year 21.3% 5 Year 27.9% 10 Year 15 Year Since launch 15.4% Historical Annual Returns
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Growth of 10k Over Years
Date Value 30 Nov 19 ₹10,000 30 Nov 20 ₹15,670 30 Nov 21 ₹19,186 30 Nov 22 ₹18,040 30 Nov 23 ₹23,340 30 Nov 24 ₹33,757 Asset Allocation
Asset Class Value Cash 1.42% Equity 98.47% Debt 0.11% Sector Allocation
Sector Value Health Care 95.93% Basic Materials 1.5% Financial Services 1.04% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMADrug Manufacturers - Specialty & Generic 11% ₹134 Cr 725,000
↓ -10,274 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087Drug Manufacturers - General 6% ₹70 Cr 450,660
↑ 660 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331Drug Manufacturers - Specialty & Generic 5% ₹64 Cr 208,365
↑ 8,365 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDYDrug Manufacturers - Specialty & Generic 5% ₹55 Cr 435,500 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLANDDrug Manufacturers - Specialty & Generic 4% ₹44 Cr 266,306
↑ 96,263 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296Drug Manufacturers - Specialty & Generic 4% ₹42 Cr 250,331 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSPMedical Care Facilities 4% ₹42 Cr 60,000
↓ -4,796 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843Medical Care Facilities 3% ₹40 Cr 634,445 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHLDrug Manufacturers - Specialty & Generic 3% ₹39 Cr 74,000 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERISDrug Manufacturers - Specialty & Generic 3% ₹36 Cr 275,361
Talk to our investment specialistFund Managers
Name Since Tenure Kamal Gada 2 May 22 2.5 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point Citibank N.A. India Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East), Stock Holding Corporation of India Mittal Court, ‘B’ Wing,,Nariman Point Registrar & Transfer Agent
KFin Technologies Ltd Address 138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat FAX N.A Email N.A Administrator Companies
Company Address UTI Mutual Fund UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E) Auditors
Company Address Haribhakti & Co. Chartered Accountants 42, Free Press House,4th Floor,,215, Nariman Point, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year UTI Healthcare Fund
Growth ₹290.505
↑ 2.88 30.18 % 45.89 % 21.27 % 27.94 % UTI Healthcare Fund
Normal Dividend, Payout ₹224.519
↑ 2.23 30.18 % 45.89 % 21.27 % 27.94 % UTI Healthcare Fund
Normal Dividend, Reinvestment ₹224.519
↑ 2.23 30.18 % 45.89 % 21.27 % 27.94 % Data as on 2 Dec 24